{
    "code": "02015772",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02015772",
    "time": "2016-11-18 19:01:49",
    "許可證字號": "衛署藥輸字第015772號",
    "註銷狀態": "已註銷",
    "註銷日期": "102\/11\/26",
    "註銷理由": "許可證已逾有效期",
    "有效日期": "99\/03\/18",
    "發證日期": "76\/04\/01",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00201577202",
    "中文品名": "步步朗細粒２００公絲\/公克",
    "英文品名": "BUBURONE SUBTILE GRANULES",
    "適應症": "慢性關節風濕症、關節痛、神經痛、神經炎、背腰痛、上氣道炎之消炎、鎮痛",
    "劑型": "150內服顆粒劑",
    "包裝": "袋裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "主成分略述": [
        "IBUPROFEN"
    ],
    "限制項目": "02輸　入",
    "申請商名稱": "1507601100  潮毅企業股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F260419000  TOWA PHARMACEUTICAL CO., LTD.",
        "製造廠廠址": "2-23 KAMITANOYUCHO,BEPPU CITY DOITA PREFECTURE2-11 SHINBASH-CHO, KADOMA CITY OSAKA JAPAN",
        "製造廠公司地址": "2-11 SHINBASH-CHO, KADOMA CITY OSAKA JAPAN",
        "": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses,put up in measured doses or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2808401300",
            "成分名稱": "IBUPROFEN",
            "含量描述": "200",
            "含量": "200.0000000000",
            "單位": "MG"
        }
    ]
}